相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition
Jennifer A. Jacobsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
5-Carboxylate Substituted Piperazine-2-ones as Potent and Selective MMP-2 Inhibitors
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2010)
Matrix Metalloproteinase Inhibitors A Critical Appraisal of Design Principles and Proposed Therapeutic Utility
Gyoergy Dorman et al.
DRUGS (2010)
Matrix Metalloproteinases and Neurotrauma: Evolving Roles in Injury and Reparative Processes
Haoqian Zhang et al.
NEUROSCIENTIST (2010)
Minocycline and neurodegenerative diseases
Hye-Sun Kim et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis
Lillian A. Buhler et al.
BMC NEUROSCIENCE (2009)
Active Site Ring-Opening of a Thiirane Moiety and Picomolar Inhibition of Gelatinases
Christopher Forbes et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Synthesis, Kinetic Characterization and Metabolism of Diastereomeric 2-(1-(4-Phenoxyphenylsulfonyl)ethyl)thiiranes as Potent Gelatinase and MT1-MMP Inhibitors
Major Gooyit et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
A Potent Gelatinase Inhibitor with Anti-Tumor-Invasive Activity and its Metabolic Disposition
Mijoon Lee et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Roles of matrix metalloproteinases in flow-induced outward vascular remodeling
Ryo Ota et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Overcoming Macrophage-Mediated Axonal Dieback Following CNS Injury
Sarah A. Busch et al.
JOURNAL OF NEUROSCIENCE (2009)
Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury
Krishna Kumar Veeravalli et al.
NEUROBIOLOGY OF DISEASE (2009)
Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors
Xian-Chao Cheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors:: Part 2.: Optimization of α-amino substituents
Shyh-Ming Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Multiphasic roles for matrix metalloproteinases after stroke
Anna Rosell et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats
Megan Ryan Detloff et al.
EXPERIMENTAL NEUROLOGY (2008)
Carbamoylphosphonate matrix metalloproteinase inhibitors 6:: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor -: Synthesis and pharmacodynamic and pharmacokinetic analysis
Amnon Hoffman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Matrix Metalloproteinase-9 Facilitates Glial Scar Formation in the Injured Spinal Cord
Jung-Yu C. Hsu et al.
JOURNAL OF NEUROSCIENCE (2008)
Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury
Fengshan Yu et al.
JOURNAL OF NEUROTRAUMA (2008)
Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection
Diego Romero-Perez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage
Hideo Kobayashi et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain
Yasuhiko Kawasaki et al.
NATURE MEDICINE (2008)
Effect of cytokines on neuronal excitability
Maria Schaefers et al.
NEUROSCIENCE LETTERS (2008)
MMPs in the central nervous system: Where the good guys go bad
Smriti M. Agrawal et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Inhibition of MMP2/MMP9 after spinal cord trauma reduces apoptosis
Alexis B. C. Dang et al.
SPINE (2008)
Metabolism of a highly selective gelatinase inhibitor generates active metabolite
Mijoon Lee et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Targeting MMPs in acute and chronic neurological conditions
V. Wee Yong et al.
NEUROTHERAPEUTICS (2007)
Dopamine receptor modulation of hypoxic-ischemic neuronal injury in striatum of newborn piglets
Zeng-Jin Yang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Cytokine regulation of MMP-9 in peripheral glia: Implications for pathological processes and pain in injured nerve
Sharmila Chattopadhyay et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction
James Haorah et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Macrophage-derived matrix metalloproteinase-2 and-9 promote the progression of cerebral aneurysms in rats
Tomohiro Aoki et al.
STROKE (2007)
Matrix metalloproteinases and proteoglycans in axonal regeneration
Michael A. Pizzi et al.
EXPERIMENTAL NEUROLOGY (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors
Li Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells
Arie Reijerkerk et al.
FASEB JOURNAL (2006)
Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction
Natthanej Luplerdlop et al.
EMBO REPORTS (2006)
Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury
Jung-Yu C. Hsu et al.
JOURNAL OF NEUROSCIENCE (2006)
Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
CM Overall et al.
NATURE REVIEWS CANCER (2006)
Recent advances in MMP inhibitor design
JF Fisher et al.
CANCER AND METASTASIS REVIEWS (2006)
Tetracyclines: Nonantibiotic properties and their clinical implications
AN Sapadin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Sodium channels and mechanisms of neuropathic pain
M Devor
JOURNAL OF PAIN (2006)
Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031
T Ishikawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Metalloproteinases: Mediators of pathology and regeneration in the CNS
VW Yong
NATURE REVIEWS NEUROSCIENCE (2005)
Ischemia injury alters endothelial cell properties of kidney cortex:: Stimulation of MMP-9
A Caron et al.
EXPERIMENTAL CELL RESEARCH (2005)
Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors
M Lee et al.
ORGANIC LETTERS (2005)
Design, synthesis, and evaluation of a mechanism-based inhibitor for gelatinase A
M Ikejiri et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia
ZZ Gu et al.
JOURNAL OF NEUROSCIENCE (2005)
Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)
SH Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Regeneration beyond the glial scar
J Silver et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11
M Matziari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The promise of minocycline in neurology
VW Yong et al.
LANCET NEUROLOGY (2004)
The TIMPs tango with MMPs and more in the central nervous system
SJ Crocker et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor
E Maquoi et al.
CLINICAL CANCER RESEARCH (2004)
Matrix metalloproteinase inhibitor development and the remodeling of drug discovery
JT Peterson
HEART FAILURE REVIEWS (2004)
Blood-spinal cord barrier after spinal cord injury: Relation to revascularization and wound healing
WD Whetstone et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3
LA Reiter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Synthesis and structure-activity relationship of α-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis
V Aranapakam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury
PJ Siddall et al.
PAIN (2003)
Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13
V Knäuper et al.
FEBS LETTERS (2002)
Benzodiazepine inhibitors of the MMPs and TACE
FC Nelson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation
JS Alexander et al.
JOURNAL OF ANATOMY (2002)
Chondroitinase ABC promotes functional recovery after spinal cord injury
EJ Bradbury et al.
NATURE (2002)
Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model
BL Lokeshwar et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors
CK Wada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines
P Heikkila et al.
ANTI-CANCER DRUGS (2002)
Metalloproteinases in biology and pathology of the nervous system
VW Yong et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770
ML Curtin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites
Y Duchossoy et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position
JI Levin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases
JI Levin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2
M Toth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Metalloproteinase increases in the injured rat spinal cord
R de Castro et al.
NEUROREPORT (2000)
Potent and selective mechanism-based inhibition of gelatinases
S Brown et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
分享论文
